According to the study, three patients were hospitalized in May 2009 with MRSA after receiving epidural injections. To evaluate what contributed to the infections, researchers retrospectively studied patients who received injections during a three-week period and compliance to infection control protocols.
The researchers found eight of 110 patients met the case definition for laboratory-confirmed infection or clinical evidence of infection. During this time, the researchers also observed inadequate use of face masks and skin preparation on patients. In addition, epidural infection syringes were reused.
The researchers suggested these infection control lapses most likely contributed to the infections.
Related Articles on Infection Control:
Review of Literature Shows Challenge of Controlling Blood Glucose Levels
New Jersey Hospital Performance Report Shows Improvement, But Room for Growth
6 Ways to Reduce Bloodstream Infections in Hospital-Based Outpatient Dialysis Centers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
